NHS is most often covered alongside Antibiotics, which appears in 1 of these 2 stories. That works out to roughly 0.6 stories per week across a 22-day span. Source depth averages 2.5 original sources per story, versus 2.6 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about NHS
NHS is most often covered alongside Antibiotics, which appears in 1 of these 2 stories. That works out to roughly 0.6 stories per week across a 22-day span. Source depth averages 2.5 original sources per story, versus 2.6 across the same-window beat baseline. At 6, the average consequence score sits below the same-window beat average of 6.2. The clearest coverage concentration is earnings: 1 of 2 stories, with the rest divided among 1 other category. This profile follows 2 Finance stories mentioning NHS across the period from February 19, 2026 to March 12, 2026.
Stories tracked
2
Per week
0.6
Sources per story
2.5
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 1713 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering NHS. Shared-story counts are live from our verified record — not editorial picks.
Target Healthcare REIT and Primary Health Properties have issued notices for their upcoming financial results, highlighting a critical period for the UK's specialized healthcare real estate sector. These announcements come as investors look for stability in inflation-linked yields and demographic-driven growth within the care home and primary care markets.
Health experts and economists are advocating for a subscription-based 'Netflix' model for antibiotics to combat the rise of superbugs. This proposed shift aims to decouple pharmaceutical profits from sales volume, incentivizing R&D in a sector currently plagued by market failure.
NHS is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.